Article Figures & Data
Tables
- Table 1
Characteristics of the study population
Controls (n = 259) Cases MSI-H (n = 40; 22%) MSI-L/MSS (n = 144; 78%) Pa Age (in yrs, mean ± SD) 61.8 ± 10.0 61.9 ± 10.1 61.8 ± 10.4 0.97 Sex (% women) 47.5 45.0 45.8 0.93 Family history of colorectal cancer (%) 11.5 16.7 21.1 0.56 Body mass index (kg/m2, mean ± SD) 26.0 ± 3.8 27.3 ± 5.4 25.5 ± 4.0 0.06 Ever smoked (%) 69.1 67.5 70.4 0.72 Dietary factors (g/day, mean ± SD) Vegetables 207.9 ± 124.2 168.4 ± 75.4 170.6 ± 82.1 0.88 Fruit 230.8 ± 180.6 214.7 ± 167.1 214.6 ± 160.6 0.996 Red meat 73.9 ± 34.1 69.2 ± 38.0 81.1 ± 35.2 0.07 Fish 18.2 ± 21.2 20.2 ± 26.7 22.3 ± 33.8 0.72 Dairy products 268.2 ± 244.3 351.0 ± 337.4 322.5 ± 330.1 0.63 Alcoholb 13.7 ± 17.6 18.7 ± 23.6 15.9 ± 25.3 0.53 Dietary fiberb 28.8 ± 8.3 27.6 ± 10.0 27.0 ± 8.3 0.70 Calciumb (mg/day) 1254.3 ± 406.3 1263.4 ± 436.9 1275.0 ± 424.4 0.88 Vitamin Cb (mg/day) 117.5 ± 53.8 93.5 ± 42.9 105.5 ± 53.8 0.19 Total energy intake (kJ/day) 9362 ± 2844 10783 ± 3762 10197 ± 3053 0.31 Tumor characteristics Tumor location (% proximal) n.a.c 67.5 34.7 <0.01 TNM stage (% I/II) n.a. 75.0 58.3 0.07 -
a MSI-H versus MSI-L/MSS, t test for continuous variables and χ2 test for categorical variables.
-
b Adjusted for total energy intake by regression analysis, for women and men separately.
-
c n.a., not applicable.
-
- Table 2
Dietary factors and MSIa in sporadic colon carcinomas: case-control and case-case comparisons
ORs (95% CIs)b T1 T2 T3 Ptrend Continuousc Vegetables (g/day) ≤166 166–223 >223 /106 No. MSI-H/MSS/controls 20/70/87 12/45/87 8/29/85 40/144/259 All cases vs. controls 1.0 0.6 (0.4–1.0) 0.4 (0.2–0.6) <0.01 0.6 (0.5–0.8) MSI-H vs. controls 1.0 0.5 (0.2–1.2) 0.4 (0.1–0.9) 0.02 0.6 (0.4–0.9) MSS vs. controls 1.0 0.7 (0.4–1.1) 0.4 (0.2–0.7) <0.01 0.6 (0.5–0.8) MSI-H vs. MSS 1.0 0.9 (0.4–2.0) 0.8 (0.3–2.2) 0.67 0.9 (0.6–1.5) Fruit (g/day) ≤142 142–269 ≥269 /164 No. MSI-H/MSS/controls 15/51/87 15/49/85 10/44/87 40/144/259 All cases vs. controls 1.0 0.9 (0.6–1.5) 0.7 (0.5–1.2) 0.22 0.9 (0.7–1.0) MSI-H vs. controls 1.0 1.0 (0.4–2.3) 0.6 (0.2–1.4) 0.21 0.8 (0.6–1.2) MSS vs. controls 1.0 0.9 (0.6–1.5) 0.8 (0.5–1.3) 0.40 0.9 (0.7–1.1) MSI-H vs. MSS 1.0 1.1 (0.5–2.6) 0.7 (0.3–1.8) 0.47 0.9 (0.7–1.4) Red meat (g/day) <58 58–87 ≥87 /43 No. MSI-H/MSS/controls 16/33/85 11/56/87 13/55/87 40/144/259 All cases vs. controls 1.0 1.3 (0.8–2.1) 1.2 (0.7–1.9) 0.60 1.1 (0.8–1.4) MSI-H vs. controls 1.0 0.6 (0.3–1.5) 0.5 (0.2–1.2) 0.11 0.6 (0.4–1.0) MSS vs. controls 1.0 1.6 (1.0–2.8) 1.5 (0.9–2.6) 0.19 1.2 (0.9–1.6) MSI-H vs. MSS 1.0 0.3 (0.1–0.8) 0.3 (0.1–0.9) 0.03 0.5 (0.3–0.9) Fish (g/day) <7 7–19 >19 /20 No. MSI-H/MSS/controls 15/43/82 9/41/91 16/60/86 40/144/259 All cases vs. controls 1.0 0.8 (0.5–1.3) 1.1 (0.7–1.7) 0.62 1.1 (0.9–1.2) MSI-H vs. controls 1.0 0.6 (0.2–1.5) 0.9 (0.4–1.9) 0.84 1.0 (0.7–1.3) MSS vs. controls 1.0 0.8 (0.5–1.4) 1.2 (0.7–2.0) 0.43 1.1 (0.9–1.3) MSI-H vs. MSS 1.0 0.6 (0.2–1.6) 0.6 (0.3–1.4) 0.27 0.9 (0.7–1.1) Dairy products (g/day) ≤117 117–305 >305 /287 No. MSI-H/MSS/controls 12/45/87 12/48/86 16/51/86 40/144/259 All cases vs. controls 1.0 1.0 (0.6–1.6) 1.0 (0.6–1.6) 0.87 1.1 (0.9–1.4) MSI-H vs. controls 1.0 0.9 (0.4–2.3) 1.1 (0.5–2.7) 0.70 1.2 (0.8–1.7) MSS vs. controls 1.0 1.0 (0.6–1.6) 0.9 (0.5–1.6) 0.77 1.1 (0.9–1.4) MSI-H vs. MSS 1.0 1.0 (0.4–2.5) 1.3 (0.5–3.2) 0.54 1.1 (0.8–1.5) Alcohold (g/day) <3.8 3.8–12.9 >12.9 /18.4 No. MSI-H/MSS/controls 12/57/86 10/31/87 18/56/86 40/144/259 All cases vs. controls 1.0 0.8 (0.5–1.3) 1.2 (0.7–1.9) 0.30 1.1 (1.0–1.4) MSI-H vs. controls 1.0 1.2 (0.5–3.2) 1.9 (0.8–4.7) 0.13 1.2 (0.9–1.7) MSS vs. controls 1.0 0.7 (0.4–1.2) 1.0 (0.6–1.8) 0.49 1.1 (0.9–1.4) MSI-H vs. MSS 1.0 1.7 (0.6–4.6) 1.7 (0.7–4.1) 0.36 1.1 (0.9–1.4) Dietary fiberd (g/day) <25 25–31 >31 /10.3 No. MSI-H/MSS/controls 17/69/86 11/32/87 12/43/86 40/144/259 All cases vs. controls 1.0 0.5 (0.3–0.8) 0.6 (0.4–1.0) 0.03 0.7 (0.6–1.0) MSI-H vs. controls 1.0 0.8 (0.3–1.8) 0.7 (0.3–1.7) 0.48 0.8 (0.5–1.3) MSS vs. controls 1.0 0.5 (0.3–0.8) 0.6 (0.3–1.0) 0.03 0.7 (0.5–0.9) MSI-H vs. MSS 1.0 1.6 (0.6–3.9) 1.2 (0.5–2.9) 0.71 1.1 (0.7–1.8) Calciumd (mg/day) ≤1062 1062–1358 >1358 /458.3 No. MSI-H/MSS/controls 12/48/87 13/35/86 15/61/86 40/144/259 All cases vs. controls 1.0 0.9 (0.6–1.5) 1.3 (0.8–2.1) 0.22 1.0 (0.8–1.3) MSI-H vs. controls 1.0 1.4 (0.6–3.4) 1.5 (0.6–3.5) 0.42 1.1 (0.7–1.5) MSS vs. controls 1.0 0.8 (0.5–1.4) 1.3 (0.8–2.2) 0.24 1.0 (0.8–1.3) MSI-H vs. MSS 1.0 1.8 (0.7–4.5) 1.1 (0.4–2.6) 0.99 1.0 (0.7–1.5) Vitamin Cd (mg/day) ≤89 89–133 >133 /68.5 No. MSI-H/MSS/controls 17/62/87 18/49/86 5/33/86 40/144/259 All cases vs. controls 1.0 0.9 (0.5–1.4) 0.5 (0.3–0.8) <0.01 0.7 (0.5–0.9) MSI-H vs. controls 1.0 1.2 (0.5–2.5) 0.3 (0.1–0.8) 0.03 0.5 (0.3–0.8) MSS vs. controls 1.0 0.8 (0.5–1.3) 0.5 (0.3–0.9) 0.02 0.7 (0.6–1.0) MSI-H vs. MSS 1.0 1.3 (0.6–2.9) 0.5 (0.2–1.6) 0.38 0.7 (0.4–1.2) -
a The subset MSI-L/MSS is, for brevity, called MSS in this table.
-
b Adjusted for age, sex, body mass index, and total energy intake. Alcohol is additionally adjusted for cigarette smoking. Trend was assessed using the median values of the tertiles as continuous variables.
-
c Per interquartile range (Q3 to Q1).
-
d Adjusted for total energy intake by regression analysis, for women and men separately.
-
- Table 3
Expression of hMLH1 and hMSH2 and hMLH1 promoter methylation statusa N (%)
All tumors (n = 184) MSI-H (n = 40) MSI-L/MSS (n = 144) Hypermethylation Yes (n = 20) No (n = 17) hMLH1 absent 26 (14) 26 (65) 0 17 (85) 7 (41) hMSH2 absent 6 (3) 6 (15) 0 0 6 (35) hMLH1 and hMSH2 present 152 (83) 8 (20) 144 (100) 3 (15) 4 (24) -
a The hMLH1 promoter methylation status of three MSI-H tumors could not be determined.
-